Evolution Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Evolution Wealth Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-111	Closed	-$63K	–	581
2021 Q3	$63K	Sell	111 -63	-36%	-$34.6K	0.01%	183
2021 Q2	$88K	Buy	174 +3	+2%	+$1.42K	0.02%	168
2021 Q1	$78K	Sell	171 -5	-3%	-$2.39K	0.02%	165
2020 Q4	$82K	Sell	176 -51	-22%	-$23.9K	0.02%	145
2020 Q3	$100K	Sell	227 -11	-5%	-$4.54K	0.03%	141
2020 Q2	$86K	Buy	238 +69	+41%	+$23.1K	0.03%	120
2020 Q1	$48K	Sell	169 -80	-32%	-$25.2K	0.02%	115
2019 Q4	$81K	Buy	249 +232	+1,365%	+$70.3K	0.02%	123
2019 Q3	$5K	Sell	17 -225	-93%	-$64.4K	﹤0.01%	287
2019 Q2	$71K	Buy	+242	New	+$66.7K	0.03%	71

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Evolution Wealth Advisors's TMO Position: Q4 2021 in Review

Evolution Wealth Advisors sold out of Thermo Fisher Scientific (TMO) in Q4 2021, closing a stake of 111 shares — an estimated $63K sold.

Evolution Wealth Advisors first reported a position in TMO in Q2 2019 and held it in 10 quarters. The position peaked at $100K in Q3 2020. 2,342 funds tracked by Wall St. Rank hold TMO as of Q4 2021.

Evolution Wealth Advisors reported no remaining Thermo Fisher Scientific position as of Q4 2021 after selling out during the quarter.
Evolution Wealth Advisors sold 111 Thermo Fisher Scientific shares in Q4 2021, an estimated $63K.
Evolution Wealth Advisors first reported a position in Thermo Fisher Scientific in Q2 2019 and held it in 10 quarters.
Evolution Wealth Advisors's Thermo Fisher Scientific position peaked at $100K in Q3 2020.
2,342 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2021.

Based on Evolution Wealth Advisors's 13F filing for Q4 2021, filed 28 Jan 2022.